Keros Therapeutics, Inc. (KROS) Earnings
|
Expand Research on KROS
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +124.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | -$0.86 | N/A | N/A | $493K | N/A | N/A | N/A | ||
| 3/4/26 | Q425 | -$0.86 | -$0.70 | -$0.16 | $385K | $2.76M | N/A |  | | Details | |
| 11/5/25 | Q325 | -$0.18 | -$1.05 | +$0.87 | $14.26M | $6.33M | N/A | | | Details | |
| 11/3/25 |
Q325 | N/A | -$1.05 | N/A | N/A | $6.33M | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$1.05 | N/A | N/A | $6.33M | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | -$0.76 | -$1.13 | +$0.37 | $18.17M | $4.21M | N/A | | | Details | |
| 7/31/25 |
Q225 | N/A | -$1.13 | N/A | N/A | $4.21M | N/A | N/A | N/A | ||
| 5/6/25 | Q125 | $3.62 | -$1.19 | +$4.81 | $211.25M | $1.26M | N/A | | | Details |
